235960043	235960043	CD	B-NP	O
|	|	NN	I-NP	O
LHMC	LHMC	NN	I-NP	O
|	|	NN	I-NP	O
47251002	47251002	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
987967	987967	CD	B-NP	O
|	|	CC	I-NP	O
11/15/1996	11/15/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/14/1996	6/14/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/29/1996	11/29/1996	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
RESTRICTIVE	RESTRICTIVE	NN	B-NP	O
PULMONARY	PULMONARY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
OBSTRUCTIVE	OBSTRUCTIVE	NN	I-NP	O
SLEEP	SLEEP	NN	I-NP	O
APNEA	APNEA	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
CHRONIC	CHRONIC	NN	I-NP	O
HYPOXIA	HYPOXIA	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
STATUS	STATUS	NN	I-NP	O
POST	POST	NN	I-NP	O
HYPERCARBIC	HYPERCARBIC	NN	I-NP	O
RESPIRATORY	RESPIRATORY	NN	I-NP	O
ARREST	ARREST	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
OBESITY	OBESITY	NNP	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
MILD	MILD	NN	I-NP	O
HYPERTENSION	HYPERTENSION	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
RECURRENT	RECURRENT	NNP	I-NP	O
LOWER	LOWER	NNP	I-NP	O
EXTREMITY	EXTREMITY	NNP	I-NP	O
DEEP	DEEP	NNP	I-NP	O
VENOUS	VENOUS	NNP	I-NP	O
THROMBOSES	THROMBOSES	NNP	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
OSTEOARTHRITIS	OSTEOARTHRITIS	NNP	I-NP	O
SECONDARY	SECONDARY	NNP	I-NP	O
TO	TO	NNP	I-NP	O
MECHANICAL	MECHANICAL	NNP	I-NP	O
DERANGEMENTS	DERANGEMENTS	NNP	I-NP	O
SECONDARY	SECONDARY	NNP	I-NP	O
TO	TO	NNP	I-NP	O
OBESITY	OBESITY	NNP	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
TYPE	TYPE	NN	I-NP	O
II	II	CD	I-NP	O
DIABETES	DIABETES	NNS	I-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
DEPRESSION	DEPRESSION	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
51	51	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
morbidly	morbidly	RB	I-NP	O
obese	obese	JJ	I-NP	O
black	black	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thromboses	thrombos	NNS	I-NP	O
requiring	require	VBG	B-VP	O
multiple	multiple	JJ	B-NP	O
hospitalizations	hospitalization	NNS	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
for	for	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Evaluation	Evaluation	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
effusion	effusion	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
derangement	derangement	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
tap	tap	NN	I-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
crystals	crystal	NNS	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
supposed	suppose	VBN	I-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
home	home	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
inadequate	inadequate	JJ	B-NP	O
support	support	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
overnight	overnight	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
.	.	.	O	O

Overnight	Overnight	RB	B-ADVP	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
Vistaril	Vistaril	NNP	B-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
some	some	DT	B-NP	O
Demerol	Demerol	NN	I-NP	O
and	and	CC	I-NP	O
Oxycodone	Oxycodone	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
unresponsive	unresponsive	JJ	B-ADJP	O
with	with	IN	B-PP	O
bloody	bloody	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
dripping	drip	VBG	B-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Code	Code	NNP	I-NP	O
Green	Green	NNP	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
find	find	VB	I-VP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

Dopamine	Dopamine	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

Narcan	Narcan	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
recovered	recover	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
awakened	awaken	VBD	B-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
initial	initial	JJ	I-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
intubation	intubation	NN	B-NP	O
was	be	VBD	B-VP	O
7.04	7.04	CD	B-NP	O
pH	pH	NN	I-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
137	137	CD	I-NP	O
and	and	CC	O	O
pO2	pO2	NN	B-NP	O
of	of	IN	B-PP	O
85	85	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
restrictive	restrictive	JJ	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Past	Past	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
FEV	FEV	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
56th	56th	JJ	I-NP	O
percentile	percentile	NN	I-NP	O
and	and	CC	I-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
59th	59th	JJ	I-NP	O
percentile	percentile	NN	I-NP	O
,	,	,	O	O
TLC	TLC	NN	B-NP	O
of	of	IN	B-PP	O
3.3	3.3	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
54th	54th	JJ	I-NP	O
percentile	percentile	NN	I-NP	O
and	and	CC	I-NP	O
DLCO	DLCO	NN	I-NP	O
at	at	IN	B-PP	O
116th	116th	JJ	B-NP	O
percentile	percentile	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
long	long	JJ	B-NP	O
term	term	NN	I-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
between	between	IN	B-PP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

Arterial	Arterial	JJ	B-NP	B-protein
blood	blood	NN	I-NP	I-protein
gases	gas	NNS	I-NP	I-protein
on	on	IN	B-PP	O
prior	prior	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
have	have	VBP	B-VP	O
revealed	reveal	VBN	I-VP	O
pO2	pO2	NN	B-NP	O
in	in	IN	B-PP	O
50	50	CD	B-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
40s	40s	CD	I-NP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
50s	50	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
with	with	IN	B-PP	O
even	even	RB	B-NP	O
trace	trace	VB	I-NP	O
apnea	apnea	NN	B-NP	O
screen	screen	NN	I-NP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
of	of	IN	B-PP	O
1994	1994	CD	B-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
19	19	CD	I-NP	O
apnea	apnea	NN	I-NP	O
events	event	NNS	I-NP	O
in	in	IN	B-PP	O
just	just	RB	B-NP	O
over	over	IN	I-NP	O
10	10	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
61	61	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
minimum	minimum	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
respiratory	respiratory	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
1995	1995	CD	B-NP	O
with	with	IN	B-PP	O
C-PAP	C-PAP	NN	B-NP	B-protein
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
apnea	apnea	NN	I-NP	O
episodes	episode	VBZ	B-VP	O
to	to	TO	B-PP	O
19	19	CD	B-NP	O
events	event	NNS	I-NP	O
in	in	IN	B-PP	O
about	about	RB	B-NP	O
480	480	CD	I-NP	O
minutes	minute	NNS	I-NP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
decreasing	decrease	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
71	71	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Apparently	Apparently	RB	B-ADVP	O
,	,	,	O	O
by	by	IN	B-PP	O
report	report	NN	B-NP	O
,	,	,	O	O
attempts	attempt	NNS	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
made	make	VBN	I-VP	O
to	to	TO	I-VP	O
start	start	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
C-PAP	C-PAP	NN	I-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
resistant	resistant	JJ	B-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
non-compliance	non-compliance	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thromboses	thrombos	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
admissions	admission	NNS	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
about	about	IN	B-NP	O
six	six	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
year	year	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1996	1996	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
1996	1996	CD	B-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
calf	calf	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
non-invasive	non-invasive	JJ	I-NP	O
studies	study	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
1996	1996	CD	B-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
apparent	apparent	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
VQ	VQ	NN	I-NP	O
scans	scan	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
it	it	PRP	B-NP	O
regularly	regularly	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
1994	1994	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
some	some	DT	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
55	55	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
or	or	CC	O	O
tricuspid	tricuspid	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
includes	include	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
Zoloft	Zoloft	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
midline	midline	NN	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	JJ	B-ADJP	O
post	post	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
tubal	tubal	JJ	I-NP	O
ligation	ligation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
hypoxemia	hypoxemia	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thromboses	thrombos	NNS	I-NP	O
and	and	CC	O	O
obstructive	obstructive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diltiazem	Diltiazem	NNP	I-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Glyburide	Glyburide	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Albuterol	Albuterol	NN	I-NP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	VBP	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
K-Dur	K-Dur	NN	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Axid	Axid	NN	I-NP	B-protein
150	150	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.h.s.	q.h.s.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	O
Zoloft	Zoloft	NNP	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Lasix	Lasix	NN	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
alternating	alternate	VBG	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
with	with	IN	B-PP	O
7.5	7.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
living	living	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
occasional	occasional	JJ	B-ADJP	O
has	have	VBZ	B-VP	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
stay	stay	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
divorced	divorce	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
refused	refuse	VBN	I-VP	O
chronic	chronic	JJ	B-NP	O
care	care	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

HABITS	HABITS	NNS	B-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
cigarettes	cigarette	NNS	B-NP	O
about	about	IN	B-PP	O
a	a	DT	B-NP	O
20	20	CD	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
intravenous	intravenous	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
status	status	NN	I-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypercarbia	hypercarbia	NN	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
underlying	underlie	VBG	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
excessive	excessive	JJ	B-NP	O
sedation	sedation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
and	and	CC	O	O
quickly	quickly	RB	B-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
interstitial	interstitial	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
extubation	extubation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	B-PP	O
bi-PAP	bi-PAP	NN	B-NP	B-protein
with	with	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
saturations	saturation	NNS	B-NP	O
between	between	IN	B-PP	O
86-90	86-90	CD	B-NP	O
%	%	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
time	time	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
work-up	work-up	NN	I-NP	O
to	to	TO	B-VP	O
search	search	VB	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
etiologies	etiology	NNS	I-NP	O
,	,	,	O	O
questioning	question	VBG	B-VP	O
possible	possible	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
vs.	vs.	IN	B-PP	O
parenchymal	parenchymal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
top	top	JJ	I-NP	O
normal	normal	JJ	I-NP	O
sized	sized	JJ	I-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
,	,	,	O	O
trace	trace	VBP	B-VP	O
tricuspid	tricuspid	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
suggested	suggest	VBN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
arterial	arterial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
mm	mm	NN	I-NP	O
of	of	IN	B-PP	O
Mercury	Mercury	NNP	B-NP	O
plus	plus	CC	O	O
the	the	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
bubble	bubble	JJ	I-NP	O
study	study	NN	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
intra-cardiac	intra-cardiac	JJ	I-NP	O
shunt	shunt	NN	I-NP	O
either	either	CC	B-PP	O
by	by	IN	B-PP	O
color	color	NN	B-NP	O
doppler	doppler	NN	I-NP	O
or	or	CC	O	O
saline	saline	NN	B-NP	O
infusion	infusion	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
exclude	exclude	VB	I-VP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
cardiomegaly	cardiomegaly	NN	B-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
patchy	patchy	JJ	B-NP	O
opacities	opacity	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
apex	apex	NN	I-NP	O
and	and	CC	I-NP	O
lung	lung	NN	I-NP	B-protein
bases	base	NNS	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
nodular	nodular	JJ	I-NP	O
quality	quality	NN	I-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
lucent	lucent	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
too	too	RB	B-ADJP	O
small	small	JJ	I-ADJP	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
help	help	VB	I-VP	O
sort	sort	VB	I-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
restrictive	restrictive	JJ	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
PA	PA	NN	I-NP	O
gram	gram	NN	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
emboli	embolus	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
emboli	embolus	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
,	,	,	O	O
elevated	elevate	VBD	B-VP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
44/13	44/13	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
mm	mm	NN	I-NP	O
of	of	IN	B-PP	O
Mercury	Mercury	NNP	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
52/2	52/2	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
mm	mm	NN	I-NP	O
of	of	IN	B-PP	O
Mercury	Mercury	NNP	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
23	23	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Service	Service	NNP	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
sort	sort	VB	I-VP	O
out	out	RP	B-PRT	O
exactly	exactly	RB	B-NP	O
what	what	WP	I-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
on	on	RP	B-PRT	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
what	what	WP	B-NP	O
the	the	DT	B-NP	O
nodular	nodular	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
described	describe	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	O
represented	represent	VBD	B-VP	O
,	,	,	O	O
whether	whether	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
inflammation	inflammation	NN	B-NP	O
or	or	CC	O	O
some	some	DT	B-NP	O
sort	sort	NN	I-NP	O
of	of	IN	B-PP	O
firm	firm	JJ	B-NP	O
nodule	nodule	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
follow-up	follow-up	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
sleep	sleep	NN	I-NP	O
study	study	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
repeat	repeat	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
impression	impression	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
restrictive	restrictive	JJ	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
attempted	attempt	VBD	B-VP	O
to	to	TO	I-VP	O
restart	restart	VB	I-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
bi-PAP	bi-PAP	NN	I-NP	B-protein
,	,	,	O	O
however	however	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
resisted	resist	VBD	B-VP	O
using	use	VBG	I-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
C-PAP	C-PAP	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
bi-PAP	bi-PAP	NN	I-NP	B-protein
practically	practically	RB	B-ADVP	O
every	every	DT	B-NP	O
night	night	NN	I-NP	O
complaining	complain	VBG	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
that	that	WDT	B-NP	O
made	make	VBD	B-VP	O
it	it	PRP	B-NP	O
difficult	difficult	JJ	B-ADJP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
wear	wear	VB	I-VP	O
the	the	DT	B-NP	O
machine	machine	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
actually	actually	RB	I-VP	O
try	try	VB	I-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
C-PAP	C-PAP	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
bi-PAP	bi-PAP	NN	I-NP	B-protein
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
labored	labor	VBN	I-VP	O
breathing	breathing	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
C-PAP	C-PAP	NN	I-NP	B-protein
at	at	IN	B-PP	O
5	5	CD	B-NP	O
mm	mm	NN	I-NP	O
of	of	IN	B-PP	O
Mercury	Mercury	NNP	B-NP	O
and	and	CC	O	O
four	four	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pulse	pulse	NN	I-NP	O
oximetry	oximetry	NN	I-NP	O
dropping	drop	VBG	B-VP	O
to	to	TO	B-PP	O
81	81	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
she	she	PRP	B-NP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
bi-PAP	bi-PAP	NN	B-NP	B-protein
with	with	IN	B-PP	O
settings	setting	NNS	B-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
mm	mm	NN	I-NP	O
of	of	IN	B-PP	O
Mercury	Mercury	NNP	B-NP	O
inspiratory	inspiratory	JJ	I-NP	O
and	and	CC	I-NP	O
7	7	CD	I-NP	O
mm	mm	NN	I-NP	O
of	of	IN	B-PP	O
Mercury	Mercury	NNP	B-NP	O
expiratory	expiratory	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
oxygen	oxygen	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
between	between	IN	B-PP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
ranged	range	VBD	B-VP	O
between	between	IN	B-PP	O
91-93	91-93	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
overnight	overnight	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
would	would	MD	B-VP	O
require	require	VB	I-VP	O
bi-PAP	bi-PAP	NN	B-NP	B-protein
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
-RRB-	-RRB-	:	O	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	IN	B-PP	O
spiked	spike	VBN	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
degrees	degree	NNS	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
never	never	RB	I-VP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
temperatures	temperature	NNS	B-NP	O
nor	nor	CC	O	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Clindamycin	Clindamycin	NN	B-NP	O
and	and	CC	I-NP	O
Ofloxacin	Ofloxacin	NN	I-NP	O
intravenously	intravenously	RB	B-ADVP	O
and	and	CC	O	O
then	then	RB	B-VP	O
switched	switch	VBD	I-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
ten	ten	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
as	as	IN	B-SBAR	O
stated	state	VBN	B-VP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
never	never	RB	B-VP	O
had	have	VBD	I-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
complain	complain	NN	B-NP	O
of	of	IN	B-PP	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
beginning	begin	VBG	B-VP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
described	describe	VBN	B-VP	O
as	as	IN	B-PP	O
general	general	JJ	B-NP	O
head	head	NN	I-NP	O
fullness	fullness	NN	I-NP	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
and	and	CC	O	O
nasal	nasal	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Afrin	Afrin	NN	B-NP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	VBN	B-VP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
relief	relief	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Robitussin	Robitussin	NNP	B-NP	O
and	and	CC	I-NP	O
Sudafed	Sudafed	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
some	some	DT	B-NP	O
maxillary	maxillary	JJ	I-NP	O
sinusitis	sinusitis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
actually	actually	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
brief	brief	JJ	I-NP	O
time	time	NN	I-NP	O
on	on	IN	B-PP	O
Afrin	Afrin	NN	B-NP	O
nasal	nasal	JJ	I-NP	O
spray	spray	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
Echocardiogram	Echocardiogram	NN	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
as	as	RB	I-VP	O
described	describe	VBN	I-VP	O
above	above	IN	B-PP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hematology	Hematology	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thromboses	thrombos	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
until	until	IN	B-SBAR	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
procedures	procedure	NNS	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
completed	complete	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
PT	PT	NN	I-NP	O
and	and	CC	I-NP	O
PTT	PTT	NN	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
point	point	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
established	establish	VBN	I-VP	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
INR	INR	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
PT	PT	NN	I-NP	O
and	and	CC	I-NP	O
PTT	PTT	NN	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
PT	PT	NN	I-NP	O
of	of	IN	B-PP	O
17.5	17.5	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
200	200	CD	I-NP	O
and	and	CC	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
PTT	PTT	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
PT	PT	NN	I-NP	O
of	of	IN	B-PP	O
18.5	18.5	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
of	of	IN	B-PP	O
67.6	67.6	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
7.5	7.5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
about	about	RB	B-NP	O
a	a	DT	I-NP	O
2	2	CD	I-NP	O
X	X	SYM	I-NP	O
2	2	CD	I-NP	O
cm	cm	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medial	medial	JJ	I-NP	O
left	left	JJ	I-NP	O
malleolus	malleolus	NN	I-NP	O
which	which	WDT	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
heal	heal	VB	I-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
granulation	granulation	NN	B-NP	O
and	and	CC	O	O
scarred	scar	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
discharged	discharge	VBN	I-VP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Rheumatology	Rheumatology	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
pain	pain	NN	I-NP	O
subsequent	subsequent	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
and	and	CC	I-NP	O
crystals	crystal	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Rheumatologist	Rheumatologist	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endocrine	Endocrine	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
maintained	maintain	VBD	B-VP	O
stable	stable	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
on	on	IN	B-PP	O
Glyburide	Glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gastrointestinal	Gastrointestinal	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
saturated	saturate	VBN	I-NP	O
fat	fat	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Axid	Axid	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
burning	burn	VBG	I-NP	O
sensation	sensation	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
throat	throat	NN	I-NP	O
after	after	IN	B-PP	O
drinking	drink	VBG	B-VP	O
orange	orange	NN	B-NP	O
juice	juice	NN	I-NP	O
which	which	WDT	B-NP	O
tended	tend	VBD	B-VP	O
to	to	TO	I-VP	O
come	come	VB	I-VP	O
and	and	CC	I-VP	O
go	go	VB	I-VP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
radiate	radiate	VB	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
from	from	IN	B-PP	O
Axid	Axid	NNP	B-NP	O
to	to	TO	B-PP	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gynecology	Gynecology	NNP	I-NP	O
:	:	:	O	O
While	While	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
started	start	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
vaginal	vaginal	JJ	I-NP	O
spotting	spotting	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
menopausal	menopausal	JJ	B-ADJP	O
since	since	IN	B-SBAR	O
her	her	PRP$	B-NP	O
40s	40	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
not	not	RB	O	O
had	have	VBD	B-VP	O
any	any	DT	B-NP	O
recent	recent	JJ	I-NP	O
gynecological	gynecological	JJ	I-NP	O
following	following	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-PP	O
either	either	CC	O	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
or	or	CC	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
GYN	GYN	NN	I-NP	O
clinic	clinic	NN	I-NP	O
at	at	IN	B-PP	O
N'ssciences	N'ssciences	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
spotting	spotting	NN	I-NP	O
for	for	IN	B-PP	O
ruling	rule	VBG	B-VP	O
out	out	RP	B-PRT	O
endometrial	endometrial	JJ	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Neurological	Neurological	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
Zoloft	Zoloft	NNP	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
General	General	NNP	I-NP	O
Care	Care	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
and	and	CC	O	O
Occupational	Occupational	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
greatly	greatly	RB	B-ADVP	O
from	from	IN	B-PP	O
inpatient	inpatient	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
or	or	CC	O	O
possibly	possibly	RB	B-ADVP	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
reduction	reduction	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
repeatedly	repeatedly	RB	B-ADVP	O
declined	decline	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
and	and	CC	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
reduction	reduction	NN	I-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
manage	manage	VB	I-VP	O
herself	herself	PRP	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	B-protein
bi-PAP	bi-PAP	NN	I-NP	I-protein
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Glyburide	Glyburide	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Procardia	Procardia	NNP	I-NP	O
XL	XL	NNP	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Zoloft	Zoloft	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	:	O	O
Ofloxacin	Ofloxacin	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
times	time	NNS	I-NP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Clindamycin	Clindamycin	NN	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

times	time	NNS	B-NP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Prilosec	Prilosec	NNP	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Potassium	Potassium	NN	I-NP	O
chloride	chloride	NN	I-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Tylenol	Tylenol	NN	I-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4-6h	4-6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Maalox	Maalox	NNP	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
indigestion	indigestion	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Albuterol	Albuterol	NNP	I-NP	O
inhaler	inhaler	NN	I-NP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Afrin	Afrin	NN	I-NP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	CD	B-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Isidro	Isidro	NNP	I-NP	O
Ernesto	Ernesto	NNP	I-NP	O
Laurila	Laurila	NNP	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
GYN	GYN	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
follow-up	follow-up	NN	I-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
On	On	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
CT	CT	NN	I-NP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
the	the	DT	B-NP	O
nodularities	nodularity	NNS	I-NP	O
found	find	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
CT.	CT.	NNP	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
Rheumatology	Rheumatology	NN	B-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
convenience	convenience	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
proceed	proceed	VB	I-VP	O
with	with	IN	B-PP	O
bi-PAP	bi-PAP	NN	B-NP	B-protein
,	,	,	O	O
however	however	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
medical	medical	JJ	B-NP	O
assistance	assistance	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
receive	receive	VB	I-VP	O
it	it	PRP	B-NP	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
CLARENCE	CLARENCE	NNP	B-NP	O
J.	J.	NNP	I-NP	O
TENBUSCH	TENBUSCH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CH94	CH94	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ANTIONE	ANTIONE	NNP	B-NP	O
WILSON	WILSON	NNP	I-NP	O
GRANVILLE	GRANVILLE	NNP	I-NP	O
CIHON	CIHON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
MB1	MB1	NN	I-NP	B-protein
MP617/3524	MP617/3524	NN	I-NP	O
Batch	Batch	NN	I-NP	O
:	:	:	O	O
85516	85516	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

CMJME99N8Y	CMJME99N8Y	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
9/7/96	9/7/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/29/96	5/29/96	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

JEREMIAH	JEREMIAH	NNP	B-NP	O
C.	C.	NNP	I-NP	O
LEANDRO	LEANDRO	NNP	I-NP	O
ZARRELLA	ZARRELLA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CC04	CC04	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

VINCENZO	VINCENZO	NNP	B-NP	O
ISADORE	ISADORE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
HOLU	HOLU	NNP	I-NP	O
SI	SI	NNP	I-NP	O
NOKEUN	NOKEUN	NNP	I-NP	O
AND	AND	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
CLINIC	CLINIC	NNP	I-NP	O
IN	IN	NNP	I-NP	O
Port	Port	NNP	I-NP	O
Chat	Chat	NNP	I-NP	O
Angelesni	Angelesni	NNP	I-NP	O

